keyword
https://read.qxmd.com/read/38585863/impaired-ampk-control-of-alveolar-epithelial-cell-metabolism-promotes-pulmonary-fibrosis
#21
Luis R Rodriguez, Konstantinos-Dionysios Alysandratos, Jeremy Katzen, Aditi Murthy, Willy Roque Barboza, Yaniv Tomer, Rebeca Acin-Perez, Anton Petcherski, Kasey Minakin, Paige Carson, Swati Iyer, Katrina Chavez, Charlotte H Cooper, Apoorva Babu, Aaron I Weiner, Andrew E Vaughan, Zoltan Arany, Orian S Shirihai, Darrell N Kotton, Michael F Beers
Alveolar epithelial type II (AT2) cell dysfunction is implicated in the pathogenesis of familial and sporadic idiopathic pulmonary fibrosis (IPF). We previously described that expression of an AT2 cell exclusive disease-associated protein isoform (SP-CI73T) in murine and patient-specific induced pluripotent stem cell (iPSC)-derived AT2 cells leads to a block in late macroautophagy and promotes time-dependent mitochondrial impairments; however, how a metabolically dysfunctional AT2 cell results in fibrosis remains elusive...
March 28, 2024: bioRxiv
https://read.qxmd.com/read/38583771/genome-wide-analysis-identifies-nuclear-factor-1c-as-a-novel-transcription-factor-and-potential-therapeutic-target-in-small-cell-lung-cancer
#22
JOURNAL ARTICLE
Vivek Shukla, Haitao Wang, Lyuba Varticovski, Songjoon Baek, Ruihong Wang, Xinwei Wu, Frank Echtenkamp, Frank Villa Hernandez, Katherine P Prothro, Sudheer K Gara, Mary R Zhang, Stephanie Shiffka, Razi Raziuddin, Leonard M Neckers, W Marston Linehan, Haobin Chen, Gordon L Hager, David S Schrump
BACKGROUND: Recent insights regarding mechanisms mediating stemness, heterogeneity, and metastatic potential of lung cancers have yet to be fully translated to effective regimens for the treatment of these malignancies. This study sought to identify novel targets for lung cancer therapy. METHODS: Transcriptomes and DNA methylomes of 14 SCLC and 10 NSCLC lines were compared to normal human small airway epithelial cells (SAEC) and induced pluripotent stem cell (iPSC) clones derived from SAEC...
April 5, 2024: Journal of Thoracic Oncology
https://read.qxmd.com/read/38582877/a-placebo-controlled-crossover-trial-to-investigate-the-efficacy-of-tiotropium-bromide-or-placebo-added-to-usual-care-in-stable-symptomatic-post-hematopoietic-stem-cell-transplantation-hsct-bronchiolitis-obliterans-syndrome-bos
#23
RANDOMIZED CONTROLLED TRIAL
Naeemeh Dini, Amin Pastaki Khoshbin, Rasoul Aliannejad, Hooman Bakhshandeh, Katayoun Najafizadeh, Mahshid Mehdizadeh, Shahideh Amini
BACKGROUND: Despite the fundamental progress in hematopoietic stem cell transplant, this treatment is also associated with complications. Graft-versus-host disease is a possible complication of HSCT. Bronchiolitis obliterans syndrome (BOS) is the pulmonary form of this syndrome. Due to the high morbidity and mortality rate of BOS, various studies have been conducted in the field of drug therapy for this syndrome, although no standard treatment has yet been proposed. According to the hypotheses about the similarities between BOS and chronic obstructive pulmonary disease, the idea of using tiotropium bromide as a bronchodilator has been proposed...
April 6, 2024: Trials
https://read.qxmd.com/read/38581619/lung-derived-soluble-factors-support-stemness-plasticity-and-metastatic-behaviour-of-breast-cancer-cells-via-the-fgf2-dach1-axis
#24
JOURNAL ARTICLE
Vasudeva Bhat, Matthew Piaseczny, David Goodale, Urvi Patel, Ashkan Sadri, Alison L Allan
Patients with triple-negative breast cancer (TNBC) have an increased propensity to develop lung metastasis. Our previous studies demonstrated that stem-like ALDHhi CD44+ breast cancer cells interact with lung-derived soluble factors, resulting in enhanced migration and lung metastasis particularly in TNBC models. We have also observed that the presence of a primary TNBC tumor can 'prime' the lung microenvironment in preparation for metastasis. In this study, we hypothesized that soluble lung-derived factors secreted in the presence of a primary TNBC tumor can influence stemness/plasticity of breast cancer cells...
April 6, 2024: Clinical & Experimental Metastasis
https://read.qxmd.com/read/38576851/multipotent-adult-progenitor-cells-prevent-functional-impairment-and-improve-development-in-inflammation-driven-detriment-of-preterm-ovine-lungs
#25
JOURNAL ARTICLE
Sophie M L Neuen, Daan R M G Ophelders, Helene Widowski, Matthias C Hütten, Tim Brokken, Charlotte van Gorp, Peter G J Nikkels, Carmen A H Severens-Rijvers, Mireille M J P E Sthijns, Clemens A van Blitterswijk, Freddy J Troost, Vanessa L S LaPointe, Shahab Jolani, Christof Seiler, J Jane Pillow, Tammo Delhaas, Niki L Reynaert, Tim G A M Wolfs
BACKGROUND: Perinatal inflammation increases the risk for bronchopulmonary dysplasia in preterm neonates, but the underlying pathophysiological mechanisms remain largely unknown. Given their anti-inflammatory and regenerative capacity, multipotent adult progenitor cells (MAPC) are a promising cell-based therapy to prevent and/or treat the negative pulmonary consequences of perinatal inflammation in the preterm neonate. Therefore, the pathophysiology underlying adverse preterm lung outcomes following perinatal inflammation and pulmonary benefits of MAPC treatment at the interface of prenatal inflammatory and postnatal ventilation exposures were elucidated...
December 2024: Regenerative Therapy
https://read.qxmd.com/read/38573476/the-main-mechanisms-of-mesenchymal-stem-cell-based-treatments-against-covid-19
#26
REVIEW
Jinling Li, Shipei He, Hang Yang, Lizeai Zhang, Jie Xiao, Chaoyi Liang, Sijia Liu
BACKGROUND: Coronavirus disease 2019 (COVID-19) has a clinical manifestation of hypoxic respiratory failure and acute respiratory distress syndrome. However, COVID-19 still lacks of effective clinical treatments so far. As a promising potential treatment against COVID-19, stem cell therapy raised recently and had attracted much attention. Here we review the mechanisms of mesenchymal stem cell-based treatments against COVID-19, and provide potential cues for the effective control of COVID-19 in the future...
April 4, 2024: Tissue Engineering and Regenerative Medicine
https://read.qxmd.com/read/38567023/combination-of-metagenomic-next-generation-sequencing-and-conventional-tests-unraveled-pathogen-profiles-in-infected-patients-undergoing-allogeneic-hematopoietic-stem-cell-transplantation-in-jilin-province-of-china
#27
JOURNAL ARTICLE
Hongyan Zou, Sujun Gao, Xiaoliang Liu, Yong Liu, Yunping Xiao, Ao Li, Yanfang Jiang
BACKGROUND: Infection is the main cause of death for patients after allogeneic hematopoietic stem cell transplantation (HSCT). However, pathogen profiles still have not been reported in detail due to their heterogeneity caused by geographic region. OBJECTIVE: To evaluate the performance of metagenomic next-generation sequencing (mNGS) and summarize regional pathogen profiles of infected patients after HSCT. METHODS: From February 2021 to August 2022, 64 patients, admitted to the Department of Hematology of The First Hospital of Jilin University for HSCT and diagnosed as suspected infections, were retrospectively enrolled...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38566174/a-wnt-mimetic-with-broad-spectrum-fzd-specificity-decreases-fibrosis-and-improves-function-in-a-pulmonary-damage-model
#28
JOURNAL ARTICLE
Mehaben Patel, Yorick Post, Natalie Hill, Asmiti Sura, Jay Ye, Trevor Fisher, Nicholas Suen, Mengrui Zhang, Leona Cheng, Ariel Pribluda, Hui Chen, Wen-Chen Yeh, Yang Li, Hélène Baribault, Russell B Fletcher
BACKGROUND: Wnt/β-catenin signaling is critical for lung development and AT2 stem cell maintenance in adults, but excessive pathway activation has been associated with pulmonary fibrosis, both in animal models and human diseases such as idiopathic pulmonary fibrosis (IPF). IPF is a detrimental interstitial lung disease, and although two approved drugs limit functional decline, transplantation is the only treatment that extends survival, highlighting the need for regenerative therapies...
April 2, 2024: Respiratory Research
https://read.qxmd.com/read/38560777/outcomes-of-patients-with-diffuse-systemic-sclerosis-eligible-for-autologous-stem-cell-transplantation-managed-with-conventional-therapy
#29
JOURNAL ARTICLE
Kate Gregory, Dylan Hansen, Ross Penglase, Diane Apostolopoulos, Gene-Siew Ngian, Wendy Stevens, Kathleen Morrisroe, Nava Ferdowsi, Laura Ross, Jennifer Walker, Helen Cooley, Peter Youssef, Kathleen Tymms, Lauren Host, Susanna Proudman, John Moore, Mandana Nikpour, Joanne Sahhar
OBJECTIVE: To determine the event-free survival of Australian patients with diffuse systemic sclerosis (dcSSc), who meet eligibility criteria for autologous stem cell transplant (ASCT) in previously published randomised controlled trials (RCTs), but were managed without ASCT. METHODS: Patients who met inclusion criteria for the ASTIS (Autologous Stem Cell Transplantation International Scleroderma)(1) and SCOT (Scleroderma: Cyclophosphamide Or Transplantation)(2) trials were identified from the multicentre Australian Scleroderma Cohort Study (ASCS)...
April 1, 2024: Arthritis & Rheumatology
https://read.qxmd.com/read/38560609/serial-bronchoalveolar-lavage-fluid-aspergillus-galactomannan-and-treatment-response-in-invasive-pulmonary-aspergillosis
#30
JOURNAL ARTICLE
Daniel Z P Friedman, Elitza S Theel, Randall C Walker, Holenarasipur R Vikram, Raymund R Razonable, Paschalis Vergidis
We studied patients diagnosed with aspergillosis based on positive bronchoalveolar lavage (BAL) Aspergillus galactomannan (GM) who had follow-up BAL sampling within 180 days. GM trend and clinical outcome were concordant in only 60% (30/50). While useful for the initial diagnosis, BAL GM trending does not always correlate with treatment response.
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38555014/in-vivo-tracking-of-mesenchymal-stem-cell-dynamics-and-therapeutics-in-lps-induced-acute-lung-injury-models
#31
JOURNAL ARTICLE
Chen Wang, Kamal Hezam, Enze Fu, Kai Pan, Yue Liu, Zongjin Li
Mesenchymal stem cells (MSCs) have been widely used to treat various inflammatory and immune-related diseases in preclinical and clinical settings. Intravital microscopy (IVM) is considered the gold standard for investigating pathophysiological conditions in living animals. However, the potential for real-time monitoring of MSCs in the pulmonary microenvironment remains underexplored. In this study, we first constructed a lung window and captured changes in the lung at the cellular level under both inflammatory and noninflammatory conditions with a microscope...
March 28, 2024: Experimental Cell Research
https://read.qxmd.com/read/38551765/osteosarcoma-cells-exhibit-functional-interactions-with-stromal-cells-fostering-a-lung-microenvironment-conducive-to-the-establishment-of-metastatic-tumor-cells
#32
JOURNAL ARTICLE
Matías J P Valenzuela Alvarez, Luciana M Gutierrez, Juan M Bayo, María J Cantero, Mariana G Garcia, Marcela F Bolontrade
BACKGROUND: Osteosarcoma (OS) stands out as the most common bone tumor, with approximately 20% of the patients receiving a diagnosis of metastatic OS at their initial assessment. A significant challenge lies in the frequent existence of undetected metastases during the initial diagnosis. Mesenchymal stem cells (MSCs) possess unique abilities that facilitate tumor growth, and their interaction with OS cells is crucial for metastatic spread. METHODS AND RESULTS: We demonstrated that, in vitro, MSCs exhibited a heightened migration response toward the secretome of non-metastatic OS cells...
March 29, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38542450/age-dependent-inflammatory-microenvironment-mediates-alveolar-regeneration
#33
JOURNAL ARTICLE
Rui Quan, Chenhong Shi, Bing Fang, Yanan Sun, Taiqi Qu, Xifan Wang, Ran Wang, Yiran Zhang, Fazheng Ren, Yixuan Li
Lung aging triggers the onset of various chronic lung diseases, with alveolar repair being a key focus for alleviating pulmonary conditions. The regeneration of epithelial structures, particularly the differentiation from type II alveolar epithelial (AT2) cells to type I alveolar epithelial (AT1) cells, serves as a prominent indicator of alveolar repair. Nonetheless, the precise role of aging in impeding alveolar regeneration and its underlying mechanism remain to be fully elucidated. Our study employed histological methods to examine lung aging effects on structural integrity and pathology...
March 20, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38542260/upregulation-of-notch-signaling-and-cell-differentiation-inhibitory-transcription-factors-in-stable-chronic-obstructive-pulmonary-disease-patients
#34
JOURNAL ARTICLE
Antonino Di Stefano, Isabella Gnemmi, Umberto Rosani, Mauro Maniscalco, Silvestro Ennio D'Anna, Paola Brun, Vitina Carriero, Francesca Bertolini, Bruno Balbi, Fabio Luigi Massimo Ricciardolo
Notch signaling is involved in the prevention of cell differentiation and cell fate in various organs, including the lungs. We aimed to determine the transcriptomic and protein expression of Notch receptors, their ligands, and related transcription factors in stable COPD. The expression and localization of Notch receptors, their ligands, and related transcription factors were measured in bronchial biopsies of individuals with stable mild/moderate (MCOPD) (n = 18) or severe/very severe (SCOPD) (n = 16) COPD, control smokers (CSs) (n = 13), and control nonsmokers (CNSs) (n = 11), and in the lung parenchyma of those with MCOPD (n = 13), CSs (n = 10), and CNSs (n = 10) using immunohistochemistry, ELISA tests, and transcriptome analyses...
March 14, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38531171/efficacy-and-safety-of-mesenchymal-stem-cell-derived-microvesicles-in-mouse-inflammatory-arthritis
#35
JOURNAL ARTICLE
Shixiong Wei, Chenyang Lu, Sujia Li, Qiuping Zhang, Ruijuan Cheng, ShuYue Pan, QiuHong Wu, Xueting Zhao, Xinping Tian, Xiaofeng Zeng, Yi Liu
OBJECTIVE: To determine the effective and safe intravenous doses of mesenchymal stem cells (MSCs)-derived microvesicles (MVs) and to elucidate the possible causes of death in mice receiving high-dose MVs. METHODS: MVs were isolated from human MSCs by gradient centrifugation. Mice with collagen-induced arthritis were treated with different doses of intravenous MVs or MSCs. Arthritis severity, white blood cell count, and serum C-reactive protein levels were measured...
March 25, 2024: International Immunopharmacology
https://read.qxmd.com/read/38530131/precision-delivery-of-human-bone-marrow-derived-mesenchymal-stem-cells-into-the-pancreas-via-intra-arterial-injection-prevents-the-onset-of-diabetes
#36
JOURNAL ARTICLE
Rosita Primavera, Shobha Regmi, Reza Yarani, Steven Levitte, Jing Wang, Abantika Ganguly, Shashank Chetty, Michele Guindani, Camillo Ricordi, Everett Meyer, Avnesh S Thakor
Mesenchymal stem cells (MSCs) are a promising therapy to potentially treat diabetes given their potent anti-inflammatory and immune-modulatory properties. While these regenerative cells have shown considerable promise in cell culture, their clinical translation has been challenging. In part, this can be attributed to these cells not reaching the pancreas to exert their regenerative effects following conventional intravenous (IV) injection, with the majority of cells being trapped in the lungs in the pulmonary first-pass effect...
March 26, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38527840/-metagenomic-next-generation-sequencing-for-the-diagnosis-of-pneumocystis-jirovecii-pneumonia-after-allogeneic-hematopoietic-stem-cell-transplantation
#37
JOURNAL ARTICLE
R Fu, R Lin, Z P Fan, F Huang, N Xu, L Xuan, Y F Huang, H Liu, K Zhao, Z X Wang, L Jiang, M Dai, J Sun, Q F Liu
Objectives: To investigate the value of metagenomic next-generation sequencing (mNGS) in the diagnosis of Pneumocystis jirovecii pneumonia (PJP) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) . Methods: The data of 98 patients with suspected pulmonary infection after allo-HSCT who underwent pathogen detection from bronchoalveolar lavage fluid between June 2016 and August 2023 at Nanfang Hospital were analyzed. The diagnostic performance of mNGS, conventional methods, and real-time quantitative polymerase chain reaction (qPCR) for PJP were compared...
January 14, 2024: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/38526067/past-and-future-of-alveolar-organoids-for-lung-regenerative-medicine
#38
JOURNAL ARTICLE
Ryuta Mikawa, Shimpei Gotoh
The lung is regarded as having limited regenerative capacity, and there are few treatment options for refractory lung diseases, such as interstitial pneumonia. Lung transplantation is the final option available in some scenarios. Research in this area has been slow owing to the complex structure of the lung for efficient gas exchange between the alveolar spaces and capillaries as well as the difficulty in obtaining specimens from patients with progressive lung disease. However, basic research over the past decade in the field of mouse and human embryology using genetic lineage tracing techniques and stem cell biology using primary and pluripotent stem cell-derived alveolar organoids has begun to clarify the tissue response in various intractable lung diseases and the mechanisms underlying remodeling...
March 25, 2024: Stem Cells
https://read.qxmd.com/read/38521410/use-of-eculizumab-in-pediatric-patients-with-high-risk-transplant-associated-thrombotic-microangiopathy-outcomes-and-risk-factors-associated-with-response-and-survival-a-retrospective-study-on-behalf-of-the-spanish-group-for-hematopoietic-transplantation-and
#39
JOURNAL ARTICLE
M I Benítez-Carabante, D Bueno, L Alonso García, I López Torija, J Marsal, Fernandez NavarroJM, M L Uria Oficialdegui, M Panesso, B Molina, C Beléndez Bieler, P Palomo, A Pérez Martínez, C Diaz-de-Heredia
INTRODUCTION: Transplant-associated thrombotic microangiopathy (TA-TMA) is associated with high morbidity and mortality. Although with the introduction of eculizumab the survival has significantly improved, there is still a need for improvement, especially in high-risk patients. OBJECTIVES: This study aims to describe the results obtained with eculizumab in a pediatric cohort with the attempt to define which risk factors could determine the response to treatment...
March 21, 2024: Transplantation and cellular therapy
https://read.qxmd.com/read/38521369/l-methionine-accentuates-anti-tumor-action-of-gefitinib-in-gefitinib-resistant-lung-adenocarcinoma-role-of-egfr-erk-akt-signaling-and-histone-h3k36me2-alteration
#40
JOURNAL ARTICLE
Swagata Pal, Shaheen Wasil Kabeer, Kulbhushan Tikoo
Adenocarcinoma, the predominant subtype of non-small cell lung cancer (NSCLC), poses a significant clinical challenge due to its prevalence and aggressive nature. Gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor is often susceptible to development of resistance despite being the preferred treatment option for NSCLC. In this study, we investigated the potential of L-Methionine in enhancing the cytotoxicity of Gefitinib and preventing resistance development. In vitro experiment employing the H1975 cell line demonstrated a notable enhancement in cytotoxic efficacy when L-Methionine (10 mM) was combined with Gefitinib, as indicated by a substantial reduction in IC50 values (155...
March 21, 2024: Toxicology and Applied Pharmacology
keyword
keyword
88417
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.